本科 salary overview

How is the salary and benefits at Guangzhou Baiyunshan Xingqun (Pharmaceutical) Joint-stock Co., Ltd. 本科? Are the salaries high at 本科?Salary range: ¥2K-30K, with 73.9% of positions earning 3-8K, 本科销售类 positions lead with 65.2%%.

本科 salary range: 2K - 30K, where 73.9% of positions earn ¥3-8K

8.7% 2-3K ***  ? 3-4.5K 17.4% 4.5-6K ***  ? 6-8K 4.3% 8-10K 8.7% 10-15K 4.3% 20-30K

Note: the salary statistics for Guangzhou Baiyunshan Xingqun (Pharmaceutical) Joint-stock Co., Ltd.本科 are based on 23 salary records from the past year. The data depends on the position samples and is for reference only.

￥3-8K

73.9% of positions earn

Average salary for this position

Note: the average salary is analyzed based on job postings published by the company. We recommend reviewing it together with position type, education, region and experience.

本科 salary changes over the years

Note: the data depends on salary samples of online job postings in the corresponding years and does not fully represent the actual situation within the company. For reference only.

Guangzhou Baiyunshan Xingqun (Pharmaceutical) Joint-stock Co., Ltd.本科Salary range: 2-3K: %, 4.5-6K: %, 8-10K: %, 10-15K: %, 20-30K: %. . Disclaimer: statistics are based on job posting analysis and do not represent the actual situation of current employees; system stability may affect objectivity, so please treat the data as reference only. Data inaccurate? Report it

Manage

本科 salary by department: 销售类 is the most common

Which departments does Guangzhou Baiyunshan Xingqun (Pharmaceutical) Joint-stock Co., Ltd.本科 have? For reference only.

Salaries for hot jobs of 本科

Are salaries high at Guangzhou Baiyunshan Xingqun (Pharmaceutical) Joint-stock Co., Ltd.本科? We provide: 销售, 管培生, 实习生, 信息, 质量, 产品经理, 副部长, 财务. Click to view detailed salary analysis by job.

本科 salary list/ranking

Position Region Salary↓ (posted by company)

Note: Guangzhou Baiyunshan Xingqun (Pharmaceutical) Joint-stock Co., Ltd. employee salarydata is collected from public salary information published on various websites by the company in the past year. For reference only.